Rapt Therapeutics Inc (NASDAQ:RAPT)

24.13
Delayed Data
As of Sep 30
 +0.26 / +1.09%
Today’s Change
9.86
Today|||52-Week Range
40.74
-34.30%
Year-to-Date
SECTOR
Health Technology
INDUSTRY
Pharmaceuticals: Major
MARKET CAP
$666.4M

Company Description

Rapt Therapeutics, Inc. operates as a clinical stage immunology-based biopharmaceutical company. It focuses on discovering, developing and commercializing oral small molecule therapies for patients in oncology and inflammatory diseases.. The company was founded in 2015 and is headquartered in South San Francisco, CA.

Contact Information

Rapt Therapeutics, Inc.
561 Eccles Avenue
South San Francisco California 94080
P:(650) 489-9000
Investor Relations:

Employees

Shareholders

Other institutional39.24%
Mutual fund holders37.27%
Individual stakeholders31.05%

Top Executives

Brian Russell WongPresident, Chief Executive Officer & Director
Rodney K. B. YoungChief Financial Officer & Secretary
William HoChief Medical Officer
Dirk G. BrockstedtChief Scientific Officer
Jim FarmerVice President-Clinical Operations